Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.58M Buy
7,345
+46
+0.6% +$16.4K 1.31% 17
2025
Q4
$2.39M Buy
7,299
+5,452
+295% +$1.73M 1.24% 13
2025
Q3
$521K Buy
1,847
+1,452
+368% +$421K 0.2% 97
2025
Q2
$110K Sell
395
-7,450
-95% -$2.11M 0.06% 249
2025
Q1
$2.44M Buy
7,845
+6,882
+715% +$2.03M 1% 18
2024
Q4
$275K Buy
+963
New +$286K 0.13% 155

Other funds holding AMGN

AmeriFlex Group's AMGN Position: Q1 2026 in Review

AmeriFlex Group increased its Amgen (AMGN) stake by 0.63% in Q1 2026, buying an estimated $16.4K and bringing the position to 7,345 shares worth $2.58M. The position accounts for 1.31% of the portfolio, ranked #17.

AmeriFlex Group first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • AmeriFlex Group held 7,345 shares of Amgen worth $2.58M as of Q1 2026.
  • AmeriFlex Group bought 46 Amgen shares in Q1 2026, an estimated $16.4K.
  • Amgen made up 1.31% of AmeriFlex Group's portfolio in Q1 2026, its #17 holding.
  • AmeriFlex Group first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on AmeriFlex Group's 13F filing for Q1 2026, filed 15 May 2026.